Evaluation of RCube Health Ltd

Analysis Plan Data sampling period: We anticipate sampling data from the period October 2022 to end of January 2023 or beyond. An opportunity sample approach will be undertaken. Main analysis For our main analyses, we will take draw down data generated at Week 1 (pre-intervention), Week 6 (post-intervention), Week 10 (follow up 1), and Week 12 (follow up 2), Specifically, the primary outcomes which will be analysed are the GAD-7, DASS-21, and the Autonomic Questionnaire. Zero order correlations will be undertaken to illustrate the relationships between these variables and descriptive statistics provided. Within-group effect sizes will be calculated to assess change over time. Additionally, between-group differences will be calculated to investigate the effect of the intervention. Effect sizes will be interpreted using the following criteria: 0.20, small effect; 0.50, medium effect; and 0.80, large effect (Cohen, 1988). It is hypothesised that there will be improvements on the GAD-7, DASS-21, and the Autonomic Questionnaire following the completion of the intervention.